Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00771030
What this trial is testing

Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Amgen 40
Early research (Phase 1)Ended earlyNCT01647620
What this trial is testing

A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.

Who this might be right for
Deep Vein Thrombosis LegStroke (in Patients With Atrial Fibrillation)
Diakron Pharmaceuticals 30
Testing effectiveness (Phase 2)Study completedNCT01230801
What this trial is testing

Safety/Tolerability/Pharmacokinetic (PK)/Pharmacodynamics (PD) Study of BMN701 in Patients With Late-Onset Pompe Disease

Who this might be right for
Pompe Disease
BioMarin Pharmaceutical 22
Early research (Phase 1)Study completedNCT00412412
What this trial is testing

CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study

Who this might be right for
Breast Cancer
Biogen 34
Early research (Phase 1)Not Yet RecruitingNCT07346690
What this trial is testing

A Study Testing the Effects of Different THC Doses on Psychological and Biological Function

Who this might be right for
Evaluate PK ProfileEvaluate PD ProfileHealthy Adults+1 more
University of Calgary 24
Early research (Phase 1)Study completedNCT03492385
What this trial is testing

Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 in Healthy Volunteers

Who this might be right for
Healthy
SFJ Pharmaceuticals, Inc. 64
Testing effectiveness (Phase 2)Study completedNCT02925650
What this trial is testing

Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Annovis Bio Inc. 18
Testing effectiveness (Phase 2)Study completedNCT03371459
What this trial is testing

Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma

Who this might be right for
Asthma
AstraZeneca 46
Early research (Phase 1)Study completedNCT03997760
What this trial is testing

SHP655 (rADAMTS13) in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Shire 19
Very early researchStudy completedNCT06109948
What this trial is testing

Study to Assess the Safety, Tolerability, PK and PD of ABX1100

Who this might be right for
HealthyLate Onset Pompe Disease
Aro Biotherapeutics 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07751744
What this trial is testing

Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal Disease, or Recurrent High Grade Glioma

Who this might be right for
Brain Metastases From Solid TumorsLeptomeningeal DiseaseHigh Grade Glioma (HGG)+1 more
Jubilant Therapeutics Inc. 113
Early research (Phase 1)Not Yet RecruitingNCT06974487
What this trial is testing

A Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injection Given Separately in Chinese Adult Overweight Subjects

Who this might be right for
Type 2 Diabetes
Gan & Lee Pharmaceuticals. 30
Early research (Phase 1)Study completedNCT04755985
What this trial is testing

Compare PK, PD and Safety of the AD-213-B and AD-2132

Who this might be right for
Gastroesophagus Reflux Disease
Addpharma Inc. 40
Large-scale testing (Phase 3)Looking for participantsNCT05710692
What this trial is testing

Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry Disease

Who this might be right for
Fabry Disease
Chiesi Farmaceutici S.p.A. 16
Testing effectiveness (Phase 2)Looking for participantsNCT06088004
What this trial is testing

Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Suzhou Abogen Biosciences Co., Ltd. 218
Early research (Phase 1)Study completedNCT01652898
What this trial is testing

A Pharmacokinetic, Pharmacodynamic, Safety Study With AOP LDLA202, ONO LDL50 and Esmolol in Healthy Volunteers

Who this might be right for
Healthy
AOP Orphan Pharmaceuticals AG 12
Testing effectiveness (Phase 2)Ended earlyNCT00314938
What this trial is testing

A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency
Pfizer 32
Early research (Phase 1)UnknownNCT05108038
What this trial is testing

Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects

Who this might be right for
GERD
Chong Kun Dang Pharmaceutical 42
Early research (Phase 1)Study completedNCT02479646
What this trial is testing

Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta

Who this might be right for
Healthy Volunteers
Mylan Inc. 218
Early research (Phase 1)Ended earlyNCT04589260
What this trial is testing

TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Theravance Biopharma 72
Next Page